Loading data for CTKB — first visit, this takes a few seconds.
Cytek Biosciences Inc. (CTKB)
NasdaqGS: CTKB
· Real-Time Price · USD
4.70
+0.03 (0.64%)
At close: Aug 19, 2026, 8:00 PM
4.70
+0.00%
After-hours: 4:10 PM
Cytek Biosciences Inc. (CTKB) Stock Price, Analysis & Data
0.64% (1D)
No data available
| Bid | 3.53 |
| Market Cap | 610.92M |
| Revenue (ttm) | 206.71M |
| Net Income (ttm) | -80.58M |
| Beta | 1.17 |
| EPS (ttm) | -0.63 |
| PE Ratio (ttm) | n/a |
| Forward PE | 67.14 |
| P/B (ttm) | 1.90 |
| P/S (ttm) | 2.96 |
| Earnings Date | Sep 2, 2021 |
| Ask | 6 |
| Volume | 872,970 |
| Avg. Volume (20D) | 1,332,262 |
| Open | 4.67 |
| Previous Close | 4.67 |
| Day's Range | 4.67 - 4.92 |
| 52-Week Range | 3.28 - 6.18 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CTKB
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle d...
Industry Medical Devices
Sector Healthcare
IPO Date Jul 23, 2021
Employees 682
Stock Exchange NasdaqGS
Ticker Symbol CTKB
Website https://cytekbio.com
Financial Performance
In 2025, Cytek Biosciences's revenue was 201.49M, an increase of 0.52% compared to the previous year's 200.45M. Earnings were -66.54M, an increase of 1,005.3%.
Financial StatementsEarnings Surprise
Cytek Biosciences has released their quarterly earnings on Aug 5, 2026:
Cytek Biosciences Inc. is scheduled to release its earnings on Sep 2, 2021, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2